by Janet L. Lathey, PhD, Scott Gregory, Mike Ewell, and Scott Hickman
Volume 5, Issue 1 (Spring 2006)
The enzyme-linked immunospot (ELISpot) assay is one of the most useful techniques for the immunological monitoring of vaccine trials and has increasing application as a measure of specific T-cell activation. Recently, we developed, optimized, and validated a customized ELISpot kit for the detection of interferon gamma (IFNγ) positive cells. The precision of the ELISpot was good and it varied over the range of the assay values, independent of the stimulus. Here we describe the development of a library of donors with characterized responses to the CEF peptide pool: cytomegalovirus (CMV), Epstein-Barr virus (EBV), and influenza (Flu); pool of 32 peptides which can be used as controls for IFNγ ELISpot and multiple immune monitoring assay validations for use in clinical trials…
Citation:
Zhang C. The Establishment and Stability of the Peripheral Blood Mononuclear Cell Donor Bank for Immunoassay Validation.BioProcess J, 2006; 5(1): 64-68. https://doi.org/10.12665/J51.Lathey